NEW YORK (GenomeWeb News) – Accelerate Diagnostics said in a document filed with the US Securities and Exchange Commission on Friday that revenues for 2013 were down 8 percent year over year.

The Tucson, Ariz.-based company did not break out revenues for the fourth quarter but based on previously disclosed financial figures for the first three quarters of the year, revenues for Q4 2013 were down 18 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.